Literature DB >> 5743278

Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector.

S H Curry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5743278     DOI： 10.1021/ac60264a031

Source DB:  PubMed          Journal:  Anal Chem        ISSN： 0003-2700            Impact factor:   6.986


× No keyword cloud information.
  20 in total

1.  Determination of free and conjugated triclosan-1 in blood by electron capture gas liquid chromatography-2.

Authors:  J Schulze; F H Marquardt; F Lyman; C Spitzer
Journal:  J Am Oil Chem Soc       Date:  1975-07       Impact factor: 1.849

2.  Cerebrospinal fluid levels of chlorpromazine and it metabolites in schizophrenia.

Authors:  S Axelsson; S Jönsson; L Nordgren
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1975-12-31

Review 3.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

4.  Preparative microfluidic electrosynthesis of drug metabolites.

Authors:  Romain Stalder; Gregory P Roth
Journal:  ACS Med Chem Lett       Date:  2013-10-01       Impact factor: 4.345

5.  Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.

Authors:  T Kolakowska; D H Wiles; M G Gelder; A S McNeilly
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

6.  Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms.

Authors:  C E Hansen; N E Larsen
Journal:  Psychopharmacologia       Date:  1974-06-18

7.  Pharmacology of chlorpromazine: clinical studies.

Authors:  S H Curray; M H Lader; G P Mould; G Sakalis
Journal:  Br J Pharmacol       Date:  1971-02       Impact factor: 8.739

8.  A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF.

Authors:  G Alfredsson; B Wode-Helgodt; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

9.  Clinical pharmacokinetic studies of perphenazine.

Authors:  C Eggert Hansen; T Rosted Christensen; J Elley; L Bolvig Hansen; P Kragh-Sorensen; N E Larsen; J Naestoft; E F Hvidberg
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

10.  Interactions of orphenadrine and phenobarbitone with chlorpromazine: plasma concentrations and effects in man.

Authors:  S Loga; S Curry; M Lader
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.